[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356309-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356309-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ep4-stimulation-promotes-cell-adhesion-and-migration-via-il-6-signaling-in-oral-squamous-cell-carcinoma","EP4 stimulation promotes cell adhesion and migration via IL-6 signaling in oral squamous cell carcinoma","","Oral squamous cell carcinoma develops within the oral cavity, and early detection improves prognosis, while progression with lymph node metastasis leads to poor outcomes. This study links prostaglandin E2 (PGE2) receptor EP4 to OSCC migration and adhesion by identifying interleukin-6 (IL-6) as a central mediator. EP4 agonist ONO-AE1–437 increased IL-6 mRNA and secretion, while EP4-overexpression elevated IL-6 even without stimulation, further enhanced by ONO-AE1–437 or PGE2. Functional assays showed PGE2-driven adhesion and migration, suppressed by EP4 antagonist ONO-AE3–208 and IL-6 inhibition.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ep4-stimulation-promotes-cell-adhesion-and-migration-via-il-6-signaling-in-oral-squamous-cell-carcinoma/356309/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ep4-stimulation-promotes-cell-adhesion-and-migration-via-il-6-signaling-in-oral-squamous-cell-carcinoma/356309.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main finding about EP4 signaling in OSCC cells?","Question",{"text":63,"@type":64},"EP4 stimulation promotes cell adhesion and migration in oral squamous cell carcinoma cells through IL-6 signaling.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the study show IL-6 involvement?",{"text":68,"@type":64},"EP4 agonist ONO-AE1–437 increased IL-6 mRNA expression and protein secretion, and inhibiting IL-6 blocked migration enhancements.",{"name":70,"@type":61,"acceptedAnswer":71},"Which pharmacologic tools were used to modulate the pathway?",{"text":72,"@type":64},"ONO-AE1–437 was used as an EP4 agonist, ONO-AE3–208 as an EP4 antagonist, and Tocilizumab was used as an IL-6 inhibitor.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356309,1790193949,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","76 (2026) 100057  \nContents lists available at ScienceDirect  \nThe Journal of Physiological Sciences  \njournal [homepage:](homepage: www.editorialmanager.com/jphyss/default2.aspx)[ www.editorialmanager.com/jphyss/default2.aspx](homepage: www.editorialmanager.com/jphyss/default2.aspx)  \n| Original article\u003Cbr>EP4 stimulation promotes cell adhesion and migration via IL-6 signaling in oral squamous cell carcinoma |  |  | |\n| --- | --- | --- | --- |\n| Wakana Fukaea, Soichiro Ishikawa b,c, Yu Iida a,d , Akane Nagasakoa, Michiko Endo a, Chihiro Hayashi a, Kagemichi Nagaod,e, Sneri Ogurib, Takayuki Fujita f, Utako Yokoyama g , Kenji Mitsudob, Yoshihiro Ishikawa h, Masanari Umemura a,*\u003Cbr>a Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan b Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa 236- 0004, Japan\u003Cbr>c Department of Clinical Oral Oncology, National hospital organization, Hokkaido Cancer Center, 2-chome, Kikusui 4-jo, Shiroishi-ku, Sapporo-shi, Hokkaido 003-0804 3-54, Japan\u003Cbr>d Department of Neurosurgery, Yokohama City University School of Medicine Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa 236- 0004, Japan\u003Cbr>e Department of Neurosurgery, Yokohama City Minato Red Cross Hospital, 3-12-1 Shinyamashita, Naka-ku, Yokohama-shi, Kanagawa 231-0801, Japan f Department of Physiology, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka-shi 814-0180, Japan\u003Cbr>g Department of Physiology, Tokyo Medical University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan h Yokohama City University President, Japan |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Prostaglandin E₂ (PGE₂) EP4\u003Cbr>Interleukin-6 (IL-6)\u003Cbr>Oral squamous cell carcinoma (OSCC) Cell adhesion\u003Cbr>Cell migration |  | Oral squamous cell carcinoma cell (OSCC) comprises malignant neoplasms arising within the oral cavity. Earlystage detection is associated with favorable prognosis, whereas progression to advanced stages with lymph node metastasis significantly worsens outcomes. We previously reported that the prostaglandin E₂ (PGE₂) receptor EP4 regulates OSCC migration. RNA sequencing reanalysis suggested that EP4 stimulation is strongly associated with cell migration and adhesion, with interleukin-6 (IL-6) emerging as a central mediator of these processes. In OSCC cells, ONO-AE1–437 (EP4 agonist) increased IL-6 mRNA expression and protein secretion. EP4-overexpressing cells showed increased IL-6 expression without stimulation, further enhanced by ONO-AE1–437 or PGE₂. xCELLigence demonstrated that PGE₂ promoted cell adhesion, which was suppressed by ONO-AE3–208 (EP4 antagonist) and Tocilizumab (IL-6 inhibitor). Scratch and transwell assays revealed enhanced migration under PGE₂ and ONO-AE1–437, blocked by IL-6 inhibition. These results suggest that EP4 promotes cell adhesion and migration through IL-6 in OSCC cells. (147 words) |  |\n\nIntroduction  \nAs a non-steroidal anti-inflammatory drug (NSAID) with acetylsalicylic acid as its active ingredient, aspirin is widely used as an analgesic and antipyretic. Aspirin has long been suggested to have preventive effects against various cancers, including oral and colorectal cancer [1],[2]. Aspirin irreversibly inhibits cyclooxygenase-2 (COX-2), an  \ninducible enzyme involved in inflammation and carcinogenesis, thereby reducing the levels of the lipid mediator prostaglandin E₂ (PGE₂) and contributing to cancer prevention [3]. COX-2 is overexpressed in a variety of cancers, and its upregulation has also been reported in oralsquamous cell carcinoma (OSCC) [4]. PGE₂ production in OSCC is COX-2-dependent, and PGE₂ plays a key role in tumor progression, invasion, immune suppression, and angiogenesis [5],[6]. Therefore, PGE₂  \nAbbreviations: COX-2, cyclooxygenase-2; GO, Enrichment: Gene Ont","cbCairFFVNeck3je","https://ap.wps.com/l/cbCairFFVNeck3je","pdf",8138030,13,"English","# Introduction\n## Aspirin, COX-2, and PGE2 in cancer prevention\n## PGE2 receptors and relevance to OSCC\n# Article information and abstract\n## Keywords and study summary","[{\"question\":\"What is the main finding about EP4 signaling in OSCC cells?\",\"answer\":\"EP4 stimulation promotes cell adhesion and migration in oral squamous cell carcinoma cells through IL-6 signaling.\"},{\"question\":\"How does the study show IL-6 involvement?\",\"answer\":\"EP4 agonist ONO-AE1–437 increased IL-6 mRNA expression and protein secretion, and inhibiting IL-6 blocked migration enhancements.\"},{\"question\":\"Which pharmacologic tools were used to modulate the pathway?\",\"answer\":\"ONO-AE1–437 was used as an EP4 agonist, ONO-AE3–208 as an EP4 antagonist, and Tocilizumab was used as an IL-6 inhibitor.\"}]","EP4 stimulation promotes cell adhesion and migration via IL-6 signaling in oral squamous cell carcinoma | PDF",1790124550,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0525fbd6d23ccdee758bf349f4d29ab.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7a8f112f4e1329d15ea77d5c302b0cc.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1912c8358ebf184e8abf27a8518f4e4b.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8fc5f713805f921a11550df0585ccbf.webp",980,1306]